Structure of human rhinovirus serotype 2 (HRV2)

Journal of Molecular Biology

Volumn 300, Issue 5, 2000, Pages 1179-1194

  Verdaguer, N ^a   Blaas, D ^b   Fita, I ^a  

^a INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Human rhinovirus; LDL receptor; Molecular replacement; Phase extension; Pocket factor

Indexed keywords

VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; CONFORMATIONAL TRANSITION; HUMAN RHINOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRAIN DIFFERENCE; VIRUS MORPHOLOGY; VIRUS TYPING;

EID: 0034725556     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.3943     Document Type: Article

References (77)

1. Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity
2. A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program - Mini-review
3. Neutralization epitopes of human rhinovirus type 2
4. Analysis of the structure of a common cold virus, human rhino-virus-14, refined at a resolution of 3.0 Å
5. Structural analysis of a series of antiviral agents complexed with human rhinovirus 14
6. Uncoating of the major group human rhinovirus HRV14 from early endosomes in the presence of bafilomycin
7. The structure of the two amino-terminal domains of human ICAM-1 suggest how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand
8. LDL receptor structure: Calcium cages, acid baths and recycling receptors
9. A dimeric structure for the N-terminal two domains of intercellular adhesion molecule-1
10. Comparison of surface properties of picornaviruses: Strategies for hiding the receptor site from immune surveillance
11. Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryo-electron microscopy and X-ray crystallography of virus-fab complexes
12. Anatomy and evolution of proteins displaying the viral capsid jellyroll topology
13. Myristilation of picornavirus capsid protein VP4 and its structural significance
14. Evidence for the direct involvement of the rhinovirus canyon in receptor binding
15. Miscellaneous algorithms for density modification
16. Rhinoviral receptor discrimination: Mutational changes in the canyon regions of human rhinovirus types 2 and 14 indicate a different site of interaction
17. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus
18. Cell-induced conformational change in poliovirus - Externalization of the amino terminus of Vp1 is responsible for liposome binding
19. Modeling of the human intercellular adhesion molecule-1, the human rhinovirus major group receptor
20. The major human rhinovirus receptor is ICAM-1
21. Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1
22. Stabilization of human rhinovirus serotype-2 against pH-induced conformational change by antiviral compounds
23. Avian homologs of the mammalian low-density lipoprotein receptor family bind minor receptor group human rhinovirus
24. The refined structure of human rhinovirus 16 at 2.15 Å resolution: Implications for the viral life cycle
25. X-ray structural analysis of bovine lactoferrin at 2.5 Å resolution
26. The crystal structure of coxackie-virus A9: New insights into the uncoating mechanisms of enteroviruses
27. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2
28. Structure of a neutralizing antibody bound monovalently to human rhinovirus 2
29. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus
30. Three-dimensional structure of parvovirus at 2.9 Å resolution
31. Acid liability of rhinovirus type 14: Effect of pH time, and temperature
32. Improved methods for building models in electron density maps and the location of errors in these models
33. Structure of two rhinovirus serotypes complexed with fragments of their cellular receptor
34. Crystal structure of human rhinovirus serotype-1A (Hrv1A)
35. A comparison of the anti-rhino-viral drug binding pocket in HRV14 and HRV1A
36. Naturally occurring and artificially produced components of three rhinoviruses
37. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
38. Structure of poliovirus type 2 Lansing complexed with antiviral agent Sch48973: Comparison of the structural and biological properties of the three poliovirus serotypes
39. Int CCP4 ESF/EACMB Newsletter
40. Antiviral agent blocks breathing of the common cold virus
41. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature
42. Comparison of in vitro and cell-mediated alteration of a human rhinovirus and its inhibition by sodium dodecyl sulfate
43. Physical and metabolic requirements for early interaction of poliovirus and human rhinovirus with HeLa cells
44. Antigenic determinants of infective and inactivated human rhino-virus type 2
45. Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection
46. Recombinant soluble low density lipoprotein receptor fragment inhibits minor group rhinovirus infection in vitro
47. Study of the parameters of binding of R-61837 to human rhinovirus-9 and immunobiochemical evidence of capsid-stabilizing activity of the compound
48. The structure of coxsackieviurs B3 at 3.5 Å resolution
49. Mechanism of entry of human rhinovirus 2 into HeLa cells
50. The structure of human rhinovirus 16
51. Structure of a human rhinovirus complexed with Its receptor molecule
52. Conformational change in the floor of the human rhino-virus canyon blocks adsorption to HeLa cell receptors
53. Uncoating of human rhinovirus serotype 2 from late endosomes
54. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance
55. Structure of a human common cold virus and functional relationship to other picornaviruses
56. Major and minor-receptor group human rhinoviruses penetrate from endosomes by different mechanisms
57. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14
58. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus human rhinovirus 14
59. Human Rhinovirus 2: Complete nucleotide sequence and proteolytic processing signals in the capsid protein region
60. A neutralizing epitope on human rhino-virus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2
61. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating
62. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families
63. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses
64. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1
65. Crystallization and preliminary X-Ray diffraction studies of the FAB fragment of a neutralizing monoclonal antibody directed against human rhinovirus stereo-type-2
66. 3-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype-2
67. Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2
68. Docking of a human rhinovirus neutralizing antibody onto the viral capsid
69. Rhinoviruses: A description
70. The major and minor group receptor families contain all but one human rhinovirus serotype
71. The pentamer channel stiffening model for drug action on human rhinovirus HRV-1A
72. Crystallization and preliminary X-ray analysis of human rhinovirus serotype 2 (HRV2)
73. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E
74. The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
75. Human rhinovirus 3 at 3.0 Å resolution